RAC Strategic Regulatory Planning 4

Question 1

A company wants to expand an approved drug's indication. Which US regulatory mechanism most strategically minimizes development burden if supportive data already exists?

Accepted Answer

Submit a Prior Approval Supplement (PAS) or efficacy supplement to the existing NDA

Answer

An efficacy supplement (Prior Approval Supplement) to an existing NDA is the standard and most efficient pathway to expand approved indications using existing or new clinical data.

Question 2

What is the role of a Target Product Profile (TPP) in regulatory strategy?

Accepted Answer

It defines the desired product attributes that drive regulatory, clinical, and CMC development decisions

Answer

The TPP articulates the minimum and ideal characteristics of the final product, aligning all development functions — including regulatory — around shared goals from the outset.

Question 3

Under FDA's rolling review process, what is the primary strategic benefit for sponsors?

Accepted Answer

Sponsors can submit completed sections of the NDA/BLA as data become available, potentially shortening overall review time

Answer

Rolling review allows FDA to begin evaluating completed modules before the full dossier is submitted, compressing the review timeline for products with expedited designations.

Question 4

When assessing regulatory risk in a strategic plan, which factor would MOST increase risk for a first-in-class drug?

Accepted Answer

Lack of regulatory precedent for the mechanism of action and uncertainty about acceptable endpoints

Answer

First-in-class drugs face heightened regulatory risk because there is no precedent for acceptable endpoints, biomarkers, or safety expectations, requiring more agency interaction and potentially novel approaches.

Question 5

Which international regulatory framework specifically harmonizes technical requirements for pharmaceuticals to reduce global development redundancy?

Accepted Answer

ICH (International Council for Harmonisation)

Answer

ICH harmonizes pharmaceutical technical requirements across the US, EU, and Japan through guidelines covering quality, safety, efficacy, and multidisciplinary topics.

(RAC) Regulatory Affairs Certification Practice Test

(RAC) Regulatory Affairs Certification Practice Test

RAC Strategic Regulatory Planning 4